Cocrystal Pharma names interim CEO
This article was originally published in Scrip
Dr Gary Wilcox has stepped down as CEO of Cocrystal Pharma – a company focused on developing novel antiviral therapeutics for human diseases – due to medical reasons. As a result, Jeffrey Meckler has been appointed interim CEO of the company. Dr Wilcox will become the vice-chair of Cocrystal's board of directors and will continue as a senior advisor to the company. Mr Meckler will continue as a director of the company, and Dr Raymond F Schinazi will become the chair of the board.